Galectin Therapeutics Inc. GALT
3.02 USD 0.00 (+0.00%)
Regular-session close
3.02 0.00 0.00%
After hours · Nov 16, 4:00 PM ET
2.93 Day range 3.21
2.03 52-week range 7.13
- YTD
- -27.40%
- 1 year
- -45.19%
News
globenewswire.com Galectin Therapeutics Reports September 30, 2026 Financial Results and Provides Business Update NORCROSS, Ga., Nov. 16, 2026 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today reported financial results and…benzinga.com Galectin Therapeutics Q3 EPS $(0.04) Beats $(0.05) Estimate Galectin Therapeutics (NASDAQ:GALT) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.05) by 20 percent. This is a 69.23 percent increase over losses of…
